A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy - PubMed (original) (raw)
Comparative Study
A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy
C M Nutting et al. Radiother Oncol. 2001 Nov.
Abstract
Background and purpose: To investigate the potential of intensity-modulated radiotherapy (IMRT) to reduce lung irradiation in the treatment of oesophageal carcinoma with radical radiotherapy.
Materials and methods: A treatment planning study was performed to compare two-phase conformal radiotherapy (CFRT) with IMRT in five patients. The CFRT plans consisted of anterior, posterior and bilateral posterior oblique fields, while the IMRT plans consisted of either nine equispaced fields (9F), or four fields (4F) with orientations equal to the CFRT plans. IMRT plans with seven, five or three equispaced fields were also investigated in one patient. Treatment plans were compared using dose-volume histograms and normal tissue complication probabilities.
Results: The 9F IMRT plan was unable to improve on the homogeneity of dose to the planning target volume (PTV), compared with the CFRT plan (dose range, 16.9+/-4.5 (1 SD) vs. 12.4+/-3.9%; P=0.06). Similarly, the 9F IMRT plan was unable to reduce the mean lung dose (11.7+/-3.2 vs. 11.0+/-2.9 Gy; P=0.2). Similar results were obtained for seven, five and three equispaced fields in the single patient studied. The 4F IMRT plan provided comparable PTV dose homogeneity with the CFRT plan (11.8+/-3.3 vs. 12.4+/-3.9%; P=0.6), with reduced mean lung dose (9.5+/-2.3 vs 11.0+/-2.9 Gy; P=0.001).
Conclusions: IMRT using nine equispaced fields provided no improvement over CFRT. This was because the larger number of fields in the IMRT plan distributed a low dose over the entire lung. In contrast, IMRT using four fields equal to the CFRT fields offered an improvement in lung sparing. Thus, IMRT with a few carefully chosen field directions may lead to a modest reduction in pneumonitis, or allow tumour dose escalation within the currently accepted lung toxicity.
Similar articles
- Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Lomax AJ, et al. Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):785-92. doi: 10.1016/s0360-3016(02)04210-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573766 - Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland.
Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C, Dearnaley DP, Webb S. Nutting CM, et al. Radiother Oncol. 2001 Aug;60(2):173-80. doi: 10.1016/s0167-8140(01)00382-6. Radiother Oncol. 2001. PMID: 11439212 - Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques.
Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, Conway J, Webb S. Nutting CM, et al. Radiother Oncol. 2001 Aug;60(2):163-72. doi: 10.1016/s0167-8140(01)00339-5. Radiother Oncol. 2001. PMID: 11439211 Clinical Trial. - [Dosimetric comparison between intensity-modulated radiotherapy and conformal radiotherapy for upper thoracic esophageal carcinoma].
Zhang WZ, Chen ZJ, Li DR, Lin ZX, Li DS, Chen CZ. Zhang WZ, et al. Ai Zheng. 2009 Nov;28(11):1127-31. doi: 10.5732/cjc.008.10839. Ai Zheng. 2009. PMID: 19895730 Chinese.
Cited by
- Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes.
Combs SE, Konkel S, Schulz-Ertner D, Münter MW, Debus J, Huber PE, Thilmann C. Combs SE, et al. Radiat Oncol. 2006 Jul 21;1:23. doi: 10.1186/1748-717X-1-23. Radiat Oncol. 2006. PMID: 16859556 Free PMC article. - Current management of esophageal cancer.
Law S, Wong J. Law S, et al. J Gastrointest Surg. 2005 Feb;9(2):291-310. doi: 10.1016/j.gassur.2004.06.007. J Gastrointest Surg. 2005. PMID: 15694827 Review. No abstract available. - The utility of proton beam therapy with concurrent chemotherapy for the treatment of esophageal cancers.
Lin SH. Lin SH. Cancers (Basel). 2011 Oct 28;3(4):4090-101. doi: 10.3390/cancers3044090. Cancers (Basel). 2011. PMID: 24213126 Free PMC article. - Heart Dose and Outcomes in Radiation Treatment for Esophageal Cancer.
Macomber MW, Bowen SR, Gopan O, Yeung R, Apisarnthanarax S, Zeng J, Patel S. Macomber MW, et al. Cureus. 2018 Mar 27;10(3):e2378. doi: 10.7759/cureus.2378. Cureus. 2018. PMID: 29805947 Free PMC article. - Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?
Wu Z, Xie C, Hu M, Han C, Yi J, Zhou Y, Yuan H, Jin X. Wu Z, et al. J Appl Clin Med Phys. 2014 May 8;15(3):93–101. doi: 10.1120/jacmp.v15i3.4641. J Appl Clin Med Phys. 2014. PMID: 24892336 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical